Physician profile
John Rose
NPI 1255623567
$1,246.48
in general payments reported to CMS, 2019-2025
7 companies · $30.03 in 2025
The $30.03 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $61.33 · 2023: $214 · 2024: $941 · 2025: $30.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $871 · Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $871.08 |
| Food and Beverage | $314.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Microinstruments, INC. | $871.08 | 2024 | Symani Surgical Systems |
| Tela Bio, INC. | $126.25 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $118.26 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Boston Scientific Corporation | $61.33 | 2022 | |
| Polynovo North America LLC | $28.65 | 2024 | Novosorb Btm |
| Integra Lifesciences Corporation | $21.44 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Rti Surgical, INC | $19.47 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.